Department of Infectious Diseases, The Second Hospital of Anhui Medical University, Hefei, 230601, China.
Institute of Clinical Virology, The Second Hospital of Anhui Medical University, Hefei, 230601, China.
Virol Sin. 2020 Dec;35(6):758-767. doi: 10.1007/s12250-020-00273-8. Epub 2020 Aug 4.
Reverse transcription-polymerase chain reaction (RT-PCR) is an essential method for specific diagnosis of SARS-CoV-2 infection. Unfortunately, false negative test results are often reported. In this study, we attempted to determine the principal causes leading to false negative results of RT-PCR detection of SARS-CoV-2 RNAs in respiratory tract specimens. Multiple sputum and throat swab specimens from 161 confirmed COVID-19 patients were tested with a commercial fluorescent RT-PCR kit targeting the ORF1ab and N regions of SARS-CoV-2 genome. The RNA level of a cellular housekeeping gene ribonuclease P/MRP subunit p30 (RPP30) in these specimens was also assessed by RT-PCR. Data for a total of 1052 samples were retrospectively re-analyzed and a strong association between positive results in SARS-CoV-2 RNA tests and high level of RPP30 RNA in respiratory tract specimens was revealed. By using the ROC-AUC analysis, we identified Ct cutoff values for RPP30 RT-PCR which predicted false negative results for SARS-CoV-2 RT-PCR with high sensitivity (95.03%-95.26%) and specificity (83.72%-98.55%) for respective combination of specimen type and amplification reaction. Using these Ct cutoff values, false negative results could be reliably identified. Therefore, the presence of cellular materials, likely infected host cells, are essential for correct SARS-CoV-2 RNA detection by RT-PCR in patient specimens. RPP30 could serve as an indicator for cellular content, or a surrogate indicator for specimen quality. In addition, our results demonstrated that false negativity accounted for a vast majority of contradicting results in SARS-CoV-2 RNA test by RT-PCR.
逆转录-聚合酶链反应(RT-PCR)是 SARS-CoV-2 感染特异性诊断的基本方法。然而,常报告假阴性检测结果。在本研究中,我们试图确定导致呼吸道标本中 SARS-CoV-2 RNA 的 RT-PCR 检测假阴性结果的主要原因。采用针对 SARS-CoV-2 基因组 ORF1ab 和 N 区的商用荧光 RT-PCR 试剂盒,对 161 例确诊 COVID-19 患者的多个痰和咽拭子标本进行了检测。还通过 RT-PCR 评估了这些标本中细胞管家基因核糖核酸酶 P/MRP 亚单位 p30(RPP30)的 RNA 水平。共回顾性分析了 1052 份样本的数据,结果显示 SARS-CoV-2 RNA 检测阳性结果与呼吸道标本中 RPP30 RNA 水平较高之间存在强烈关联。通过 ROC-AUC 分析,我们确定了 RPP30 RT-PCR 的 Ct 截止值,用于预测 SARS-CoV-2 RT-PCR 的假阴性结果,其对各自的标本类型和扩增反应组合的灵敏度(95.03%-95.26%)和特异性(83.72%-98.55%)均较高。使用这些 Ct 截止值,可以可靠地识别假阴性结果。因此,细胞物质(可能是受感染的宿主细胞)的存在对于 RT-PCR 在患者标本中正确检测 SARS-CoV-2 RNA 是必不可少的。RPP30 可以作为细胞含量的指标,或标本质量的替代指标。此外,我们的结果表明,RT-PCR 检测 SARS-CoV-2 RNA 的假阴性结果占 RT-PCR 检测假阴性结果的绝大多数。